HSP Inhibitor Sensitize Resistant MCF-7 Cells to Doxorubicin through Suppressing HSP90AB4P Pseudogene and HSPB1 Expression.
- DOI
- 10.2174/0118715206374072250530103333
- Published
- 2026
- Container
- Anti-cancer agents in medicinal chemistry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2174/0118715206374072250530103333,
title = {HSP Inhibitor Sensitize Resistant MCF-7 Cells to Doxorubicin through Suppressing HSP90AB4P Pseudogene and HSPB1 Expression.},
author = {Coskun KA and Tutar L and Abay EC and Gulum L and Celik AB and Gumus M and Koca I and Tutar Y},
year = {2026},
journal = {Anti-cancer agents in medicinal chemistry},
doi = {10.2174/0118715206374072250530103333},
url = {https://doi.org/10.2174/0118715206374072250530103333}
}RIS
TY - JOUR TI - HSP Inhibitor Sensitize Resistant MCF-7 Cells to Doxorubicin through Suppressing HSP90AB4P Pseudogene and HSPB1 Expression. AU - Coskun KA AU - Tutar L AU - Abay EC AU - Gulum L AU - Celik AB AU - Gumus M AU - Koca I AU - Tutar Y PY - 2026 JO - Anti-cancer agents in medicinal chemistry DO - 10.2174/0118715206374072250530103333 UR - https://doi.org/10.2174/0118715206374072250530103333 ER -
APA
KA, C., L, T., EC, A., L, G., AB, C., M, G., I, K., & Y, T. (2026). HSP Inhibitor Sensitize Resistant MCF-7 Cells to Doxorubicin through Suppressing HSP90AB4P Pseudogene and HSPB1 Expression.. Anti-cancer agents in medicinal chemistry. https://doi.org/10.2174/0118715206374072250530103333
Source records
- pubmed · retrieved 2026-09-27T08:18:32.315Z